Results 11 to 20 of about 37,095 (249)

Risk of abnormal pregnancy outcomes after using ondansetron during pregnancy: A systematic review and meta-analysis

Frontiers in Pharmacology, 2022
Background: Hyperemesis gravidarum is a serious pregnancy complication that affects approximately 1% of pregnancies worldwide.Objective: To determine whether the use of ondansetron during pregnancy is associated with abnormal pregnancy outcomes.Search ...
Xiao Cao, Mingyao Sun, QiuYu Yang, Qi Wang, Liangying Hou, Jing Wang, Yu Wu, Long Ge, Long Ge   +8 more
doaj   +1 more source

Association of ABCB1, 5-HT3B receptor and CYP2D6 genetic polymorphisms with ondansetron and metoclopramide antiemetic response in Indonesian cancer patients treated with highly emetogenic chemotherapy. [PDF]

, 2011
Our study shows that in Indonesian cancer patients treated with highly cytostatic emetogenic, carriership of the CTG haplotype of the ABCB1 gene is related to an increased risk of delayed chemotherapy-induced nausea and ...
Baak-Pablo, Renee F, Gelderblom, Hans, Guchelaar, Henk-Jan, Hakimi, Mohammad, Mustofa, Mustofa, Nortier, Johann W R, Perwitasari, Dyah A, van der Straaten, Robert J H M, Wessels, Judith A M   +8 more
core   +2 more sources

Prophylactic Antiemetic Effects of Midazolam, Ondansetron and their Combination after Middle Ear Surgery

مجله دانشکده پزشکی اصفهان, 2016
Background: The purpose of the present study was to evaluate the efficacy of midazolam-ondansetron combination in prevention of postoperative nausea and vomiting (PONV) after middle ear surgery and its comparison with using midazolam or ondansetron alone.
Azim Honarmand, Seyed Mohammad Reza Safavi, Mansoureh Chegeni   +2 more
doaj   +3 more sources

The effect of oral ondansetron on QT interval in children with acute gastroenteritis; a retrospective observational study

BMC Pediatrics, 2021
Background In mildly to moderately dehydrated patients with acute gastroenteritis (AGE), oral rehydration therapy (ORT) is the treatment of choice. Though ondansetron is a very effective antiemetics and leads to succeed ORT, there have been reports QT ...
Heewon Yang, Woochan Jeon, Yura Ko, Sooin Jeong, Jisook Lee   +4 more
doaj   +1 more source

Cisplatin-induced emesis: systematic review and meta-analysis of the ferret model and the effects of 5-HT3 receptor antagonists [PDF]

, 2010
PURPOSE: The ferret cisplatin emesis model has been used for ~30 years and enabled identification of clinically used anti-emetics. We provide an objective assessment of this model including efficacy of 5-HT(3) receptor antagonists to assess its ...
A Fink-Jensen, A Lehmann, A Ozaki, AG King, AH Lau, AL Harris, AM Holmes, AP Florczyk, AP Florczyk, B Costall, B Costall, B Costall, B Costall, B Costall, B Costall, B Lasheras, C Bountra, C. C. Apfel, CJ Gardner, CJ Gardner, CJ Gardner, CL Gooch, D Moher, D Spina, D Tattersall, D Tattersall, DG Altman, DJ Reynolds, DR Gandara, E Blum, E Chevalier, F Roila, FD Tattersall, FD Tattersall, FD Tattersall, GA Higgins, GJ Hollingworth, H Nakayama, H Yamakuni, H Yamakuni, HE Marr, HE Marr, HE Marr, HL Borison, I Angel, I Monkovic, IT Jantunen, J Bermudez, J Hawthorn, J Horn, J Horn, J. A. Rudd, JA Gylys, JA Rudd, JA Rudd, JA Rudd, JA Rudd, JA Rudd, JA Rudd, JA Rudd, JA Rudd, JA Rudd, JA Rudd, JA Rudd, JA Rudd, JA Rudd, JE Schurig, JH Kim, JJ Hale, JJ Hale, JM Barnes, JN Matthews, JW Watson, K Haga, K Haga, L Singh, LE McCarthy, LR Fitzpatrick, LX Cubeddu, M Martin, M Marty, M Minami, M Minami, M Minami, M Ohta, M Tsuchiya, MD Sickle Van, MG Kris, MG Kris, MR Macleod, MR Macleod, MR Macleod, MT Price, N Fukunaka, N Percie du Sert, N Yoshida, N Yoshida, N Yoshida, N Yoshida, N. Percie du Sert, NM Barnes, NM Barnes, NM Rupniak, P Bhandari, P Delagrange, P Pound, P Preziosi, P Ruff, P. L. R. Andrews, PJ Hesketh, PJ Hesketh, PLR Andrews, PLR Andrews, PR Blower, R DerSimonian, R Hargreaves, R Stables, RA Matthews, RC Miller, RD Clark, RD Youssefyeh, RD Youssefyeh, RM Eglen, RM Eglen, RM Eglen, RM Navari, S Bingham, S Gonsalves, S Taniguchi, T Endo, T Endo, T Endo, T Endo, T Endo, T Ito, T Kamato, T Kamato, T Matsui, T Yoshikawa, T Yoshikawa, T Yoshikawa, TM Dando, TS Sam, TS Sam, TS Sam, V Bebarta, WD Miner, WD Miner, WD Miner, Y Kubota, Y Shiroshita, Y Shiroshita, Y Watanabe, YL Liu   +153 more
core   +2 more sources

Comparison of droperidol and ondansetron prophylactic effect on subarachnoid morphine-induced pruritus

Brazilian Journal of Anesthesiology, 2015
Background and objectives: The prophylactic effect of ondansetron on subarachnoid morphine-induced pruritus is controversial, while evidence suggests that droperidol prevents pruritus.
Fabio Ferreira da Cunha Brião, Marcio Leal Horta, Bernardo Lessa Horta, Guilherme Antônio Moreira de Barros, Ana Paula Behrensdorf, Ingrid Severo, Mariana Antunes Nunes, Roberta Boabaid, André Real   +8 more
doaj   +1 more source

Impact of chemotherapy-induced nausea and vomiting on quality of life in indonesian patients with gynecologic cancer. [PDF]

, 2011
Patients reported a negative impact on the QoL of delayed emesis after chemotherapy. Poor prophylaxis of patients' nausea and vomiting after chemotherapy interferes with patients' QoL.
Atthobari, Jarir, Dwiprahasto, Iwan, Gelderblom, Hans, Guchelaar, Henk-Jan, Hakimi, Mohammad, Kaptein, Ad A, Mustofa, Mustofa, Nortier, Johan W R, Perwitasari, Dyah Aryani, Putter, Hein   +9 more
core   +1 more source

Phenylephrine, ondansetron, or combination of both for prevention of intraoperative nausea and vomiting in patients undergoing lower segment cesarean section: A prospective, double-blind randomized control trial

Bali Journal of Anesthesiology, 2023
Background: Intraoperative nausea and vomiting (IONV) are common complications in patients undergoing lower segment cesarean section (LSCS) under subarachnoid block.
Vikram Bedi, Pratibha Yadav, Bishan Kumar Bairwa, Santosh Choudhary, Naveen Kumar, Gayatri Deshpande   +5 more
doaj   +1 more source

Effects of ondansetron alone and in combination with domperidone in the prevention of chemotherapy-induced nausea and vomiting in breast cancer patients

Bangladesh Journal of Pharmacology, 2007
The efficacy and safety of ondansetron, administered alone and in combination with domperidone to prevent chemotherapy-induced nausea and vomiting of breast cancer patients receiving chemotherapy FAC regimen (5-fluorouracil, adriamycin and ...
Kaberi Das Gupta, A. K. M. Mosharrof Hossain, Abdur Raquib Jaigirdar, Borhan Uddin, Tridiv Choudhury, Dipti Rani Saha   +5 more
doaj   +1 more source

A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea [PDF]

, 2013
Background: Irritable bowel syndrome with diarrhoea (IBS-D) is particularly debilitating due to urgency and episodic incontinence. Some 5-hydroxytryptamine 3 (5-HT3) receptor antagonists (5-HT3RAs) have proven effective but have serious side effects ...
Amanda Henry, Andresen, Brown, Camilleri, Chang, Chang, Ching Lam, Clayton, Cremonini, Cremonini, Dunlop, Dunlop, Faure, Foley, Francis, Gershon, Gulzar Singh, Hahn, Heaton, Hirata, Ian Hall, Julia Chernova, Keating, Klara Garsed, Kozlowski, Krause, Kroenke, Levenstein, Longstreth, Luca Marciani, Marciani, Margaret Hastings, Matsueda, Matsueda, Maxton, Metcalf, Olden, Peter Whorwell, Robin Spiller, Spiegel, Spiegel, Spiller, Spiller, Talley, Tillisch, von der Ohe, Wiklund, Wolf, Zhu   +48 more
core   +2 more sources